📰 Igm Concentrate News
Igm Concentrate News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Igm Concentrate. Real-time updates on events, politics, business and more.
December 12, 2023
EQS-News: Biotest AG / Key word: Study Biotest expands its clinical development program for trimodulin to patients with community-acquired pneumonia 12.12.2023 / 09:00...
December 12, 2023
EQS-News: Biotest AG / Key word(s): StudyBiotest expands its clinical development program for trimodulin to patients with community-acquired pneumonia (CAP) 12.12.2023 / 09:00 CET/CESTThe issuer is solely responsible for the content of this announcement. PRESS RELEASE    Biotest expands its clinical d...
September 12, 2023
EQS-News: Biotest AG / Key word: Study Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin...
January 10, 2023
EQS-News: Biotest AG / Key word(s): Study Biotest AG: Biotest treats first COVID-19 patients with trimodulin in TRICOVID phase III tr...
January 10, 2023
EQS-News: Biotest AG / Key word: Study Biotest AG: Biotest treats first COVID-19 patients with trimodulin in TRICOVID phase III trial 10.01.2023 / 07:00 CET/CEST The issuer is... | January 10, 2023
November 23, 2021
DGAP-News: Biotest AG / Key word(s): Research Update23.11.2021 / 15:34 The issuer is solely responsible for the content of this announcement.PRESS RELEASEBiotest accelerates trimodulin development in hospitalized COVID-19 patients with federal funding in the volume of 29 million EUR- The German Federal Ministry of E...
June 2, 2021
DGAP-News: Biotest AG / Key word(s): Study02.06.2021 / 07:00 The issuer is solely responsible for the content of this announcement.PRESS RELEASEBiotest successfully completes recruitment for its clinical trial with trimodulin in severe COVID-19 patients - Trimodulin as potential life-saving treatment for severe COVI...